Use of a New Tumor Marker, Urinary NMP22, in the Detection of Occult or Rapidly Recurring Transitional Cell Carcinoma of the Urinary Tract Following Surgical Treatment

1996 ◽  
pp. 363-367 ◽  
Author(s):  
Mark S. Soloway ◽  
Joseph V. Briggman ◽  
Gennaro A. Carpinito ◽  
Gerald W. Chodak ◽  
Paul A. Church ◽  
...  
1996 ◽  
Vol 156 (2) ◽  
pp. 363-367 ◽  
Author(s):  
Mark S. Soloway ◽  
Joseph V. Briggman ◽  
Gennaro A. Carpinito ◽  
Gerald W. Chodak ◽  
Paul A. Church ◽  
...  

2008 ◽  
Vol 6 (1) ◽  
Author(s):  
Tawatchai Taweemonkongsap ◽  
Chaiyong Nualyong ◽  
Teerapon Amornvesukit ◽  
Sunai Leewansangtong ◽  
Sittiporn Srinualnad ◽  
...  

1993 ◽  
Vol 60 (3) ◽  
pp. 279-282
Author(s):  
P. De Carli ◽  
M. Marcellini ◽  
H. Fattahi ◽  
G. Mainiero ◽  
B.M. Ciammarughi

Transitional cell carcinoma is often multicentric in the urinary tract and urethral tumours are not infrequent in bladder cancer patients. The occurrence of urethral carcinoma is simultaneous or recurrent after radical cystectomy. The management of urethral neoplasms and results of 12 simultaneous and 10 post-cystectomy cases treated with perineal urethrectomy are reported. The Authors debate the role of primary and secondary surgical treatment and the perineal or prepubic technique. One case of urethral recurrence after orthotopic bladder substitution emphasizes that patients must be accurately evaluated to exclude urethral disease before cystoprostatectomy, and monitored for carcinoma of urethral remnant.


Cancer ◽  
2007 ◽  
Vol 110 (8) ◽  
pp. 1715-1722 ◽  
Author(s):  
Giacomo Novara ◽  
Vincenzo De Marco ◽  
Fedra Gottardo ◽  
Orietta Dalpiaz ◽  
Vianney Bouygues ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document